Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 51 clinical trials
Multisession Radiosurgery in Residual/Recurrent Grade II Meningiomas.

Fractionated radiosurgery will be delivered to atypical meningioma lesions in salvage setting for patients who present post-surgical residual lesion or develop recurrence.

  • 0 views
  • 24 Oct, 2021
  • 1 location
The Safety of Intravenous Tranexamic Acid in Patients Undergoing Supratentorial Meningiomas Resection

problem of concern, especially in neurosurgery. Therefore, this study aims to provide a scientific evidence for the safety of TXA in supratentorial meningiomas resection patients.

tranexamic acid
  • 0 views
  • 29 Oct, 2021
  • 1 location
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma

This randomized phase III trial studies how well radiation therapy works compared with observation in treating patients with newly diagnosed grade II meningioma that has been completely removed

tumor cells
intracranial meningioma
central pathology review
x-rays
ct scan
  • 1040 views
  • 15 Sep, 2022
  • 122 locations
Apatinib in the Treatment of Recurrent Atypical/Malignant Meningioma in Adults

Apatinib mesylate may be an effective treatment for recurrent atypical/malignant meningioma. This prospective clinical study is now planned to verify the effectiveness and safety of apatinib

Accepts healthy volunteers
  • 0 views
  • 24 Mar, 2022
  • 1 location
Cabozantinib for Patients With Recurrent or Progressive Meningioma

A Phase II Study of Cabozantinib for Patients with Recurrent or Progressive Meningioma

hysterectomy
platelet count
renal function
karnofsky performance status
neutrophil count
  • 0 views
  • 08 Jul, 2022
  • 1 location
Sunitinib in Treating Patients With Recurrent or Unresectable Meningioma Intracranial Hemangiopericytoma or Intracranial Hemangioblastoma

works in treating patients with recurrent or unresectable meningioma, intracranial hemangiopericytoma, or intracranial hemangioblastoma.

  • 89 views
  • 07 Nov, 2020
  • 2 locations
Effect of Tranexamic Acid on Intraoperative Blood Loss in Patients Undergoing Brain Meningioma Resections: Study Protocol of a Randomised Controlled Trial

Intra-operative blood loss of huge meningioma resection patients on average was over 1000ml. Intra-operative massive hemorrhage was associated with longer hospital of stay, higher expense, and

tranexamic acid
  • 0 views
  • 15 Sep, 2022
  • 1 location
Exploratory Study of PD-1 Neoadjuvant Treatment of Recurrent Meningioma

This research study is studying a drug as a possible treatment for High Grade Meningioma.

tumor cells
dexamethasone
recurrent meningioma
  • 1 views
  • 19 Aug, 2021
  • 1 location
Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide

Meningiomas are known to be the most frequent intracranial neoplasms and account for approx. 25-33% of all intracranial tumours.Targeted radionuclide therapy with radiolabelled somatostatin

somatostatin
dotatoc
karnofsky performance status
ct scan
peptide receptor radionuclide therapy
  • 0 views
  • 18 Aug, 2021
  • 1 location
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or

gsk2256098
tumor cells
vismodegib
  • 4 views
  • 25 Jul, 2022
  • 511 locations